DXC Systems Share Price Hits Over Five-Month High As Company Fetches Rs 483-Crore Export Order
DCX Systems Ltd.'s share price rose to the highest level in over five months as the company received export order worth Rs 483 crore from ELTA System Ltd., Israel. The order is for manufacture and supply of close-in weapon system module assemblies.
The given order value is deducted assuming $1 is equal to Rs 85, DCX Systems said in the exchange filing. The actual order value is $56.50 million, as per the exchange filing.
In an separate exchange filing, DCX Systems Ltd. said that it appointed Ramegowda Shiva Kumar as an additional executive director on the board of directors of the company with effect from Jan 2. The appointment awaiting approval from the shareholders.

DCX System Ltd. share price rose 6.53% to Rs 393.00 apiece, the highest level since Jul 29. It pared gains to trade 3.48% higher at Rs 381.75 apiece as of 9:43 a.m., as compared to 0.17% decline in the NSE Nifty 50 index.
DCX Systems Ltd. share price rose for five days in a row to Monday. The stock hit a 52-week high of Rs 451.90 on Jul 3, 2024. It touched a 52-week low of Rs 235.30 apiece on March 13.
The stock gained 10.24% in 12 months. Total traded volume so far in the day stood at 27 times its 30-day average. The relative strength index was at 71.21, which implied the stock is slightly overbought.
Three analysts tracking the company maintain a 'buy' rating, according to Bloomberg data. The average 12-month consensus price target implies an upside of 6.6%.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.